Literature DB >> 16191512

Differential DNA methylation of gene promoters in small B-cell lymphomas.

Juyuan Guo1, Matthias Burger, Inko Nimmrich, Sabine Maier, Evelyne Becker, Buelent Genc, Dieter Duff, Farahnaz Rahmatpanah, Rebecca Chitma-Matsiga, Huidong Shi, Kurt Berlin, Tim H-M Huang, Charles W Caldwell.   

Abstract

Improved care of patients with small B-cell lymphomas (SBCLs) is likely to result from the ongoing discovery of molecular markers that better define these malignant neoplasms. We identified multiple gene loci whose DNA methylation patterns differed between 3 types of SBCL: B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma, mantle cell lymphoma, and grades I and II follicular lymphoma. This analysis was performed using an oligonucleotide microarray that allowed determination of the DNA methylation status of 156 loci in 38 genes. Combined bisulfite restriction analysis and methylation-specific polymerase chain reaction were used to validate the differential methylation of 6 of these genes. By using non-Hodgkin lymphoma cell lines as models, these genes were examined further for methylation and gene expression relationships. This study illustrates nonrandom epigenetic alterations in SBCLs that seem to preferentially involve lymphomas of germinal center derivation.

Entities:  

Mesh:

Year:  2005        PMID: 16191512     DOI: 10.1309/LCGN-V77J-464L-NFD6

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

Review 1.  Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases.

Authors:  Shuk-mei Ho; Wan-yee Tang
Journal:  Reprod Toxicol       Date:  2007-01-19       Impact factor: 3.143

2.  Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma.

Authors:  Milena Krajnović; Milica Radojković; Radoslav Davidović; Bogomir Dimitrijević; Koviljka Krtolica
Journal:  Med Oncol       Date:  2012-12-30       Impact factor: 3.064

Review 3.  Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.

Authors:  Mukesh Verma; Daniela Seminara; Fernando J Arena; Christy John; Kumiko Iwamoto; Virginia Hartmuller
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

4.  The Impact of DNA Methylation in Hematopoietic Malignancies.

Authors:  Maria Guillamot; Luisa Cimmino; Iannis Aifantis
Journal:  Trends Cancer       Date:  2016-02-01

5.  TET1 is a tumor suppressor of hematopoietic malignancy.

Authors:  Luisa Cimmino; Meelad M Dawlaty; Delphine Ndiaye-Lobry; Yoon Sing Yap; Sofia Bakogianni; Yiting Yu; Sanchari Bhattacharyya; Rita Shaknovich; Huimin Geng; Camille Lobry; Jasper Mullenders; Bryan King; Thomas Trimarchi; Beatriz Aranda-Orgilles; Cynthia Liu; Steven Shen; Amit K Verma; Rudolf Jaenisch; Iannis Aifantis
Journal:  Nat Immunol       Date:  2015-04-13       Impact factor: 25.606

6.  Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.

Authors:  Xiao-Ming Wang; Timothy C Greiner; Marina Bibikova; Brian L Pike; Kimberly D Siegmund; Uttam K Sinha; Markus Müschen; Erich B Jaeger; Dennis D Weisenburger; Wing C Chan; Darryl Shibata; Jian-Bing Fan; Joseph G Hacia
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

7.  Next generation sequencing: advances in characterizing the methylome.

Authors:  Kristen H Taylor; Huidong Shi; Charles W Caldwell
Journal:  Genes (Basel)       Date:  2010-07-01       Impact factor: 4.096

8.  Array-based DNA methylation profiling in follicular lymphoma.

Authors:  C O'Riain; D M O'Shea; Y Yang; R Le Dieu; J G Gribben; K Summers; J Yeboah-Afari; L Bhaw-Rosun; C Fleischmann; C A Mein; T Crook; P Smith; G Kelly; A Rosenwald; G Ott; E Campo; L M Rimsza; E B Smeland; W C Chan; N Johnson; R D Gascoyne; S Reimer; R M Braziel; G W Wright; L M Staudt; T A Lister; J Fitzgibbon
Journal:  Leukemia       Date:  2009-07-09       Impact factor: 11.528

9.  Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma.

Authors:  Jeffrey N Bryan; Mohamed Jabbes; Linda M Berent; Gerald L Arthur; Kristen H Taylor; Kerry C Rissetto; Carolyn J Henry; Farah Rahmatpanah; Wendi V Rankin; Jose A Villamil; Michael R Lewis; Charles W Caldwell
Journal:  BMC Genet       Date:  2009-11-13       Impact factor: 2.797

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.